Cargando…

Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e

OBJECTIVE: Delineation of treatment volumes is a major source of uncertainties in radiotherapy (RT). This is also true for rectal cancer patients undergoing neoadjuvant RT, with a potential impact on treatment quality. We investigated the role of the digital platform Anatom-e (Anatom-e Information S...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Pierfrancesco, Arcadipane, Francesca, Trino, Elisabetta, Gallio, Elena, Martini, Stefania, Iorio, Giuseppe Carlo, Piva, Cristina, Moretto, Francesco, Ruo Redda, Maria Grazia, Verna, Roberta, Tseroni, Vassiliki, Bona, Cristina, Pozzi, Gabriele, Fiandra, Christian, Ragona, Riccardo, Bertetto, Oscar, Ricardi, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008279/
https://www.ncbi.nlm.nih.gov/pubmed/29928706
http://dx.doi.org/10.1016/j.ctro.2018.06.002
_version_ 1783333137312382976
author Franco, Pierfrancesco
Arcadipane, Francesca
Trino, Elisabetta
Gallio, Elena
Martini, Stefania
Iorio, Giuseppe Carlo
Piva, Cristina
Moretto, Francesco
Ruo Redda, Maria Grazia
Verna, Roberta
Tseroni, Vassiliki
Bona, Cristina
Pozzi, Gabriele
Fiandra, Christian
Ragona, Riccardo
Bertetto, Oscar
Ricardi, Umberto
author_facet Franco, Pierfrancesco
Arcadipane, Francesca
Trino, Elisabetta
Gallio, Elena
Martini, Stefania
Iorio, Giuseppe Carlo
Piva, Cristina
Moretto, Francesco
Ruo Redda, Maria Grazia
Verna, Roberta
Tseroni, Vassiliki
Bona, Cristina
Pozzi, Gabriele
Fiandra, Christian
Ragona, Riccardo
Bertetto, Oscar
Ricardi, Umberto
author_sort Franco, Pierfrancesco
collection PubMed
description OBJECTIVE: Delineation of treatment volumes is a major source of uncertainties in radiotherapy (RT). This is also true for rectal cancer patients undergoing neoadjuvant RT, with a potential impact on treatment quality. We investigated the role of the digital platform Anatom-e (Anatom-e Information Sytems Ltd., Houston, Texas) in increasing the compliance to follow a specific treatment protocol in a multicentric setting. MATERIALS AND METHODS: Two clinical cases of locally advanced rectal cancer were chosen. Participants were instructed to follow the 2009 Radiation Therapy Oncology Group consensus atlas and asked to manually segment clinical target volumes (CTVs), for both patient 1 and 2, on day 1 with and without the use of Anatom-e. After one week (day 2), the same radiation oncologist contoured again, with and without Anatom-e, the same CT series. Intraobserver (Intra-OV) and interobserver (Inter-OV) variability were evaluated with the Dice similarity coefficient (DSC), the Hausdorff distance (HD) and mean distance to agreement (MDA). RESULTS: For clinical case 1, no significant difference was found for Intra-OV and Inter-OV. For clinical case 2, no significant difference was found for Intra-OV but a statistically significant difference was found for Inter-OV in DSC when using or not the platform. Mean DCS was 0.65 (SD: ±0.64; range: 0.58–0.79) for day 1 vs reference volume without Anatom-e and 0.72 (SD: ±0.39; range: 0.67–0.77) (p = 0.03) with it. Mean MDA was lower with Anatom-e (3.61; SD: ±1.33; range: 2.85–4.78) than without (4.14; SD: ±2.97; range: 2.18–5.21), with no statistical significance (p = 0.21) The use of Anatom-e decreased the SD from 2.97 to 1.33. Mean HD was lower with Anatom-e (26.06; SD: ±2.05; range: 24.08–32.62), with no statistical significance (p = 0.14) compared to that without (31.39; SD: ±1.31; range: 26.14–48.72). CONCLUSIONS: The use of Anatom-e decreased the Inter-OV in the CTV delineation process for locally advanced rectal cancer with complex disease presentation planned for neoadjuvant RT. This system may be potentially helpful in increasing the compliance to follow shared guidelines and protocols.
format Online
Article
Text
id pubmed-6008279
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60082792018-06-20 Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e Franco, Pierfrancesco Arcadipane, Francesca Trino, Elisabetta Gallio, Elena Martini, Stefania Iorio, Giuseppe Carlo Piva, Cristina Moretto, Francesco Ruo Redda, Maria Grazia Verna, Roberta Tseroni, Vassiliki Bona, Cristina Pozzi, Gabriele Fiandra, Christian Ragona, Riccardo Bertetto, Oscar Ricardi, Umberto Clin Transl Radiat Oncol Article OBJECTIVE: Delineation of treatment volumes is a major source of uncertainties in radiotherapy (RT). This is also true for rectal cancer patients undergoing neoadjuvant RT, with a potential impact on treatment quality. We investigated the role of the digital platform Anatom-e (Anatom-e Information Sytems Ltd., Houston, Texas) in increasing the compliance to follow a specific treatment protocol in a multicentric setting. MATERIALS AND METHODS: Two clinical cases of locally advanced rectal cancer were chosen. Participants were instructed to follow the 2009 Radiation Therapy Oncology Group consensus atlas and asked to manually segment clinical target volumes (CTVs), for both patient 1 and 2, on day 1 with and without the use of Anatom-e. After one week (day 2), the same radiation oncologist contoured again, with and without Anatom-e, the same CT series. Intraobserver (Intra-OV) and interobserver (Inter-OV) variability were evaluated with the Dice similarity coefficient (DSC), the Hausdorff distance (HD) and mean distance to agreement (MDA). RESULTS: For clinical case 1, no significant difference was found for Intra-OV and Inter-OV. For clinical case 2, no significant difference was found for Intra-OV but a statistically significant difference was found for Inter-OV in DSC when using or not the platform. Mean DCS was 0.65 (SD: ±0.64; range: 0.58–0.79) for day 1 vs reference volume without Anatom-e and 0.72 (SD: ±0.39; range: 0.67–0.77) (p = 0.03) with it. Mean MDA was lower with Anatom-e (3.61; SD: ±1.33; range: 2.85–4.78) than without (4.14; SD: ±2.97; range: 2.18–5.21), with no statistical significance (p = 0.21) The use of Anatom-e decreased the SD from 2.97 to 1.33. Mean HD was lower with Anatom-e (26.06; SD: ±2.05; range: 24.08–32.62), with no statistical significance (p = 0.14) compared to that without (31.39; SD: ±1.31; range: 26.14–48.72). CONCLUSIONS: The use of Anatom-e decreased the Inter-OV in the CTV delineation process for locally advanced rectal cancer with complex disease presentation planned for neoadjuvant RT. This system may be potentially helpful in increasing the compliance to follow shared guidelines and protocols. Elsevier 2018-06-11 /pmc/articles/PMC6008279/ /pubmed/29928706 http://dx.doi.org/10.1016/j.ctro.2018.06.002 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Franco, Pierfrancesco
Arcadipane, Francesca
Trino, Elisabetta
Gallio, Elena
Martini, Stefania
Iorio, Giuseppe Carlo
Piva, Cristina
Moretto, Francesco
Ruo Redda, Maria Grazia
Verna, Roberta
Tseroni, Vassiliki
Bona, Cristina
Pozzi, Gabriele
Fiandra, Christian
Ragona, Riccardo
Bertetto, Oscar
Ricardi, Umberto
Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e
title Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e
title_full Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e
title_fullStr Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e
title_full_unstemmed Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e
title_short Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e
title_sort variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform anatom-e
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008279/
https://www.ncbi.nlm.nih.gov/pubmed/29928706
http://dx.doi.org/10.1016/j.ctro.2018.06.002
work_keys_str_mv AT francopierfrancesco variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT arcadipanefrancesca variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT trinoelisabetta variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT gallioelena variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT martinistefania variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT ioriogiuseppecarlo variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT pivacristina variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT morettofrancesco variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT ruoreddamariagrazia variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT vernaroberta variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT tseronivassiliki variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT bonacristina variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT pozzigabriele variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT fiandrachristian variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT ragonariccardo variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT bertettooscar variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome
AT ricardiumberto variabilityofclinicaltargetvolumedelineationforrectalcancerpatientsplannedforneoadjuvantradiotherapywiththeaidoftheplatformanatome